# Airflow Limitation in Cardiac Diseases in Europe

> **NCT01485159** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3000 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **PROCEDURE:** Spirometry

## Key facts

- **NCT ID:** NCT01485159
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485159, "Airflow Limitation in Cardiac Diseases in Europe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01485159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*